These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6003869)

  • 21. Editorial: Treatment of typhoid fever and typhoid carriers in Southeast Asia: --Viewpoint from the Philippines.
    Gamboa EL
    Drugs; 1975; 9(4):245-6. PubMed ID: 1126309
    [No Abstract]   [Full Text] [Related]  

  • 22. [A deficit of gammaM-antibodies in the sera of carriers of typhoid bacteria as one of the possible reasons for the incompleteness of specific immunity].
    Chernokhvostova EV; Liuksemburg KI; German GP; Shandalov BIa
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Nov; 45(11):82-8. PubMed ID: 4186106
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative study of the Vi-typhin test passive hemagglutination reaction for detection of Vi-antibodies in the blood serum and its practical significance].
    D'iachenko PN; Karagulova SK; Maslova EG; Kurbangalieva FKh; Bestuzheva tap
    Zdravookhr Kirg; 1975; (1):25-7. PubMed ID: 237378
    [No Abstract]   [Full Text] [Related]  

  • 24. Editorial: Treatment of typhoid fever and typhoid carriers in Southeast Asia: -Viewpoint form South Vietnam.
    Linh NN; Arnold K
    Drugs; 1975; 9(4):241-3. PubMed ID: 1126307
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of typhoid fever patients with high doses of Vi-antigen in association with levomycetin].
    Bunin KV; Sukhoroslova LI
    Sov Med; 1968 Sep; 31(9):17-22. PubMed ID: 5747026
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-term observations for Vi-antibody formation in patients following typhoid fever, treated with Vi-antigen in combination with levomycetin].
    Shneĭder VP
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Sep; 44(9):146. PubMed ID: 5615960
    [No Abstract]   [Full Text] [Related]  

  • 27. [Characteristics of Vi-antibody formation in typhoid fever and chronic typhoid fever bacterial carriers].
    Karmanov MI
    Sov Med; 1973 May; 36(5):149-50. PubMed ID: 4768336
    [No Abstract]   [Full Text] [Related]  

  • 28. New trends in the chemotherapy of typhoid fever.
    Herzog C
    Acta Trop; 1980 Sep; 37(3):275-80. PubMed ID: 6106368
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential agglutination of particulate Vi and O antigens by the IgM and IgG class antibodies.
    Chau PY; Ng MH
    Aust J Exp Biol Med Sci; 1978 Feb; 56(1):39-45. PubMed ID: 666676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of the role of Vi antibodies and antibodies of IgA type in the low specific bactericidal activity of the serum in typhoid carriers.
    Karolcek J; Draskovicová M; Ciznár I
    Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):247-51. PubMed ID: 1179883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The relationship between the indices of the indirect hemagglutination test using antigen from antoclaved cultures of typhoid bacteria, and the method of treating typhoid patients].
    Kuliev MM
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Apr; 45(4):47-51. PubMed ID: 5735288
    [No Abstract]   [Full Text] [Related]  

  • 32. Vi haemagglutination test for the identification of typhoid carriers.
    Anderson K
    Guys Hosp Rep; 1970; 119(2):111-7. PubMed ID: 5476849
    [No Abstract]   [Full Text] [Related]  

  • 33. Variation in the titre of agglutinins in children with typhoid fever treated with chloramphenicol.
    LEVY D; FALK W
    Ann Paediatr; 1956 Apr; 186(4):249-55. PubMed ID: 13327686
    [No Abstract]   [Full Text] [Related]  

  • 34. Influences of trimethoprim-sulphamethoxazole and chloramphenicol on immunoglobulin and antibody response in typhoid fever.
    Hsieh WC; Hsieh BS
    Southeast Asian J Trop Med Public Health; 1974 Mar; 5(1):17-21. PubMed ID: 4839076
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antiendotoxic activity of the blood sera of typhoid fever patients].
    Kotova TA; Pogorel'skaia LV; Il'inskiĭ IuA; Likhoded VG; Poverennyĭ AM
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Sep; (9):103-7. PubMed ID: 7148226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ampicillin in enteric fever.
    Thiruvengadam KV; Subramaniam S; Krishnaswamy S; Subramanian N; Sarma AV
    J Assoc Physicians India; 1970 Dec; 18(12):1019-25. PubMed ID: 4994597
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experience with the use of the Vi-hemagglutination test as a method of detecting typhoid fever bacteria carrier state].
    Koval'skaia AI; Skrypnik MI
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Oct; 43(10):141-2. PubMed ID: 6003866
    [No Abstract]   [Full Text] [Related]  

  • 38. The management of typhoid fever.
    Chan AC; Mak MH
    Trop Doct; 1976 Apr; 6(2):53-5. PubMed ID: 1265834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of erythrocyte vi-diagnosticum for detecting chronic typhoid carriers].
    Koliubakina NV; Karal'nik BV
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Oct; 42(10):111-5. PubMed ID: 5871422
    [No Abstract]   [Full Text] [Related]  

  • 40. [New developments in the complex therapy of opisthorchis and typhoid carrier state].
    Dalmatov DM
    Med Parazitol (Mosk); 1966; 35(4):423-5. PubMed ID: 5993830
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.